Provided by Tiger Trade Technology Pte. Ltd.

REMEGEN

77.100
+2.3003.07%
Volume:3.12M
Turnover:238.35M
Market Cap:43.45B
PE:51.16
High:77.500
Open:73.500
Low:73.500
Close:74.800
52wk High:126.600
52wk Low:63.300
Shares:563.61M
HK Float Shares:208.58M
Volume Ratio:1.32
T/O Rate:1.50%
Dividend:- -
Dividend Rate:- -
EPS(LYR):1.507
ROE:109.10%
ROA:39.01%
PB:4.47
PE(LYR):51.16
PS:4.65

Loading ...

Movement Alert|RemeGen Rises 4.23% in Regular Trading, A-Share Buyback Plan Enters Implementation Phase as Innovative Drug Sector Strengthens

Market Focus
·
Jul 22

Innovative Drug Stocks Rebound Swiftly, Leading ETF Surges as Sector Gains Momentum with Positive Developments from Multiple Companies

Deep News
·
Jul 20

REMEGEN Shares Surge Over 8% on Proposed A-Share Buyback and Positive Outlook for Telitacicept

Stock News
·
Jul 20

RemeGen Proposes Share Buyback of Up to 50 Million Yuan

MT Newswires Live
·
Jul 20

HK Movers | Biomedical Stocks Rally; REMEGEN, WUXI XDC and KEYMED BIO-B Surge Over 8%

Tiger Newspress
·
Jul 20

Hong Kong Stock Connect Biotech Sector Stages Strong Rebound, Key ETF Surges Over 4%; REMEGEN Announces Buyback, Leading Gains

Deep News
·
Jul 20

Hong Kong Stocks Add 2.0% in Morning Trading

Dow Jones
·
Jul 20

Movement Alert|RemeGen Rises 5.11% in Regular Trading, First A-Share Buyback Plan Boosts Market Confidence

Market Focus
·
Jul 20

Remegen Announces Share Buyback Plan Valued Between 25 Million and 50 Million Yuan

Stock News
·
Jul 19

Movement Alert|RemeGen Falls 5.06% in Regular Trading, Biotech Sector Broadly Weakens Amid Continued Lock-up Expiry Pressure

Market Focus
·
Jul 17

Movement Alert|RemeGen Rises 5.39% in Regular Trading, Telitacicept Inclusion in National Essential Drug List Continues to Drive Shares

Market Focus
·
Jul 15

REMEGEN Shares Surge Over 6% on Inclusion of Telitacicept in National Essential Drug List

Stock News
·
Jul 10

Biotech Stocks Surge as New National Essential Drug List Includes Innovative Therapies

Stock News
·
Jul 10

Movement Alert|RemeGen Rises 5.49% in Regular Trading, Core Product Telitacicept Included in New National Essential Drug List

Market Focus
·
Jul 10

Movement Alert|RemeGen Rises 5.44% in Regular Trading, High Pass Rate of National Insurance Innovative Drug Catalog Preliminary Review Catalyzes Sector Rally

Market Focus
·
Jul 08

Movement Alert|RemeGen Falls 5.01% in Regular Trading, Biotech Sector Broadly Weak After Recent Sharp Rally

Market Focus
·
Jul 07

RemeGen Reports Stable Share Base for June 2026; No New Issuance or Treasury Activity

Bulletin Express
·
Jul 06

Hong Kong Innovative Drug Stocks Jump With HAIXI PHARMA and INNOCARE up 7%; KEYMED up 5%, REMEGEN up 4%

Tiger Newspress
·
Jul 06

Movement Alert|RemeGen Rises 4.27% in Regular Trading, Lock-up Selling Pressure Constrained by Dividend Rules Boosts Sentiment

Market Focus
·
Jul 06

Movement Alert|RemeGen Rises 6.93% in Regular Trading, Innovative Drug Payment Reform Catalyzes Biotech Sector Rally

Market Focus
·
Jul 03